Adamax Dosage Calculator
Calculate Adamax nootropic peptide dosing, reconstitution volume, and syringe draw units. Includes intranasal and subcutaneous protocols. This calculator performs math conversions only — Adamax is not FDA-approved. It does not recommend doses for unsupervised use.
Adamax Research Protocol
Enter your protocol phase and parameters to see common Adamax research dosing patterns. No FDA-approved dose exists — these are math conversions from Semax-family research, not medical recommendations.
Adamax Common Research Ranges
| Phase | Dose (mcg/day) | Route | Frequency | Duration |
|---|---|---|---|---|
| Standard intranasal | 200-600 mcg | Intranasal | 1-2x daily | 10-14 days |
| Subcutaneous injection | 100-300 mcg | SubQ | 1x daily | 7-14 days |
| Lower-dose exploratory | 100-200 mcg | Intranasal | 1x daily | 5-10 days |
| Acute cognitive boost | 300-600 mcg | Intranasal | As needed | Single use |
| Extended cycle | 200-400 mcg | Intranasal/SubQ | 1-2x daily | 14-21 days |
Key Properties
- Family: Semax-family nootropic analog (ACTH 4-7 fragment)
- Half-life: ~7 minutes (active fragment in plasma); CNS effects persist longer
- Routes: Intranasal (direct CNS) or subcutaneous injection
- Legal status: Not FDA-approved — research only
- Cycle break: 1-4 weeks off between research cycles
- Oral bioavailability: Poor — must be administered parenterally
- This calculator performs math conversions only — it does not verify product quality, safety, or medical appropriateness
Reconstitution Calculator
Calculate how much bacteriostatic water to add and how many units to draw on your syringe for your Adamax subcutaneous dose. For intranasal use, calculate concentration only.
Enter values and click Calculate
How Reconstitution Works
- Determine concentration: Divide peptide amount by water volume (e.g., 5 mg ÷ 1 mL = 5 mg/mL = 5000 mcg/mL)
- Calculate draw volume: Divide your dose by concentration (e.g., 200 mcg ÷ 5000 mcg/mL = 0.04 mL)
- Convert to syringe units: Multiply mL by 100 for U-100 syringes (0.04 mL = 4U) — for SubQ route only
- For intranasal: Use concentration to determine number of sprays or drops per dose
Example Calculation (SubQ)
Vial: 5 mg Adamax
Water: 1 mL bacteriostatic
Dose: 200 mcg
Syringe: 100U (1 mL)
Concentration: 5 mg ÷ 1 mL = 5000 mcg/mL
Draw volume: 200 mcg ÷ 5000 mcg/mL = 0.04 mL = 4U on a U-100 syringe
Intranasal Conversion
For intranasal use, the concentration determines how many sprays or drops deliver the target dose. A typical nasal spray delivers approximately 100 mcg per spray at standard concentrations. Always verify the delivery volume of your specific nasal applicator.
Adamax Dosage Calculator
If you are searching for an Adamax dosage calculator, you may be trying to organize a nootropic peptide protocol into a clear plan. This calculator helps with the math — concentration, draw volume, syringe units, and phase-based scheduling for both intranasal and subcutaneous routes. It does not provide medical recommendations. Adamax is not FDA-approved and no safe therapeutic dose has been established.
What is Adamax?
Adamax is a nootropic research peptide in the Semax family. The parent compound Semax is a synthetic heptapeptide analog of the ACTH 4-7 fragment, developed in Russia and approved there for stroke treatment, cognitive enhancement, and neuroprotection. Adamax follows the same mechanism — targeting cognitive function and neurological support through direct CNS delivery. The compound has poor oral bioavailability and must be administered intranasally or via subcutaneous injection.
Intranasal vs subcutaneous dosing
The intranasal route is the primary research route for Semax-family peptides because it provides direct CNS delivery, bypassing the blood-brain barrier. Typical intranasal doses range from 200 to 600 mcg per day, divided into 1 or 2 doses. Subcutaneous injection provides more sustained systemic delivery, with doses of 100 to 300 mcg per day. The calculator above reflects both routes with appropriate dose ranges for each.
Short half-life and dosing implications
The active fragment of Semax-family peptides has a plasma half-life of approximately 7 minutes, though CNS effects persist longer due to direct neural uptake. This short half-life means the compound clears rapidly from blood, which supports divided dosing (1-2 times daily) rather than a single large dose. The calculator accounts for this by offering divided frequency options.
Safety and limitations
Adamax is not FDA-approved for any therapeutic use. Side effects are compound-specific and not fully characterized in human studies. Potential effects include nasal irritation, injection site reactions, mild headache, or transient mood changes. The compound has not undergone FDA review for safety, effectiveness, or quality. Do not combine with other CNS-active medications without medical supervision. Discuss any protocol with a licensed healthcare provider.
For a full guide on Adamax protocols, dosing charts, safety considerations, and route differences, read our Adamax Peptide Dosing Guide →